04/10/2024
3:03 PM | Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
5:47 PM | Agios Pharmaceuticals (Issuer)
Washburn Theodore James Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
5:49 PM | Agios Pharmaceuticals (Issuer)
Foster-Cheek Kaye I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:26 PM | Agios Pharmaceuticals (Subject)
Foster-Cheek Kaye I (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
5:05 PM | Agios Pharmaceuticals (Subject)
Foster-Cheek Kaye I (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
6:06 PM | Agios Pharmaceuticals (Subject)
Foster-Cheek Kaye I (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
8:21 PM | Agios Pharmaceuticals (Subject)
Schenkein David P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
02/22/2024
4:43 PM | Agios Pharmaceuticals (Issuer)
Washburn Theodore James Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
9:33 AM | Agios Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
6:03 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
4:50 PM | Agios Pharmaceuticals (Issuer)
Agios Pharmaceuticals (Issuer)
Washburn Theodore James Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
1:21 PM | Agios Pharmaceuticals (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
| Form SC 13G/A | |
02/13/2024
5:07 AM | Agios Pharmaceuticals (Subject)
BB BIOTECH AG (Filed by)
| Form SC 13G/A | |
02/12/2024
10:21 AM | Agios Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
02/12/2024
9:50 AM | Agios Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
02/08/2024
10:39 AM | Agios Pharmaceuticals (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SC 13G/A | |
01/24/2024
3:20 PM | Agios Pharmaceuticals (Issuer)
Goff Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
3:22 PM | Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
3:23 PM | Agios Pharmaceuticals (Issuer)
Jones Cecilia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
3:24 PM | Agios Pharmaceuticals (Issuer)
Gheuens Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
3:25 PM | Agios Pharmaceuticals (Issuer)
Burns James William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
11:37 AM | Agios Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/09/2024
3:25 PM | Agios Pharmaceuticals (Issuer)
Burns James William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:26 PM | Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:28 PM | Agios Pharmaceuticals (Issuer)
Goff Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:22 PM | Agios Pharmaceuticals (Issuer)
Gheuens Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
6:58 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
3:10 PM | Agios Pharmaceuticals (Issuer)
Milanova Tsveta (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
4:18 PM | Agios Pharmaceuticals (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SC 13G | |
11/09/2023
12:26 PM | Agios Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/02/2023
8:20 AM | Agios Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023
6:02 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
3:04 PM | Agios Pharmaceuticals (Issuer)
Foster-Cheek Kaye I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
8:20 AM | Agios Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/03/2023
5:38 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2023
3:02 PM | Agios Pharmaceuticals (Issuer)
Washburn Theodore James Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2023
3:07 PM | Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2023
3:09 PM | Agios Pharmaceuticals (Issuer)
Burns James William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:37 PM | Agios Pharmaceuticals (Issuer)
Ho Maykin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:38 PM | Agios Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:38 PM | Agios Pharmaceuticals (Issuer)
Foster-Cheek Kaye I (Reporting)
Foster-Cheek Kaye I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
These AI trades triggered this morning (545% return) (Ad) If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy |
06/23/2023
3:34 PM | Agios Pharmaceuticals (Issuer)
Schenkein David P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:36 PM | Agios Pharmaceuticals (Issuer)
Scadden David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:30 PM | Agios Pharmaceuticals (Issuer)
CAPELLO JEFFREY D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:32 PM | Agios Pharmaceuticals (Issuer)
Owen Catherine E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:22 PM | Agios Pharmaceuticals (Issuer)
Smith Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:23 PM | Agios Pharmaceuticals (Issuer)
Ho Maykin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:25 PM | Agios Pharmaceuticals (Issuer)
Ballal Rahul D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:26 PM | Agios Pharmaceuticals (Issuer)
Schenkein David P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:28 PM | Agios Pharmaceuticals (Issuer)
Scadden David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:29 PM | Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:13 PM | Agios Pharmaceuticals (Issuer)
Owen Catherine E. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/15/2023
3:17 PM | Agios Pharmaceuticals (Issuer)
CAPELLO JEFFREY D (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/13/2023
3:13 PM | Agios Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/04/2023
8:55 AM | Agios Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/04/2023
6:03 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
